Fluor Corporation has been chosen by VaxGen Inc. to provide services for the development of two biopharmaceutical manufacturing facilities.
Site found for biopharma plant in Switzerland
Lonza Group Limited (Basel, Switzerland) has selected a site for a cGMP facility that will produce microbial biopharmaceuticals.
Akzo Nobel expands Diosynth’s position in biotechn
Akzo Nobel has announced a new EUR 18 million investment for its Pharma business unit Diosynth to increase its biopharmaceutical upstream manufacturing capacity in Oss, The Netherlands.
Biopharmaceutical complex in Seattle
The Immunex Corporation is to build a biopharmaceutical complex in Seattle, Wahington, worth USD 750 million.
Jacobs wins hydrogen project
Jacobs Engineering Group Inc. has won a contract from Koch Petroleum Group for project and construction management services of Koch's grassroots No. 3 Hydrogen Plant.